An observational study in Atopic Dermatitis, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey. Open to participants aged 2 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-02-13.
Sponsored by Bezmialem Vakif University · Observational
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis.
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis. EASI and SCORAD values and disease duration of atopic dermatitis patients are calculated during the examination. HOMA-IR blood test result is compared with the results.
1,419 studies on the registry are indexed under Dermatitis, Atopic; 258 are open to participants now.
This study's enrollment of 32 is below the median of 150 across 237 observational studies indexed under Dermatitis, Atopic.
Browse Dermatitis, Atopic studies →Bezmialem Vakif University is the lead sponsor of 345 studies on the registry; 58 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Atopic dermatitis patients confirmed by a dermatologist
Exclusion Criteria:
HOMA-IR
Patients' blood test show the result of fasting insulin (microU/L) x fasting glucose (mmol/L)/22.5
Time frame: 12 months
SCORAD index
Severity scoring of atopic dermatitis is calculated for each patient in the study. 6 intensity items (erythema, edema/papulation, oozing/crusts, excoriations, lichenification, dryness); 2 subjective symptoms(itch, sleeplessness); body surface area are studied. Max score is 103.
Time frame: 12 months
EASI index
Eczema Area and Severity Index is calculated for each patient in the study. Body surface area, 4 intensity items(erythema, induration, excoriation, lichenification) are studied. Max score is 72.
Time frame: 12 months
Duration of the disease
The time from the first onset of symptoms of the disease to the present. The relationship between insulin resistance and disease duration is examined
Time frame: 12 months
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bezmialem Vakif University